News Ex-Novartis CMO John Tsai joins Daiichi Sankyo Daiichi Sankyo has named John Tsai as its new global head of R&D, replacing Ken Takeshita, who is stepping down after five years in the role.
News Mark Dawson named head of Roche's pRED unit Roche has appointed leading Australian cancer researcher Mark Dawson to lead its pRED R&D division, as the company prepares for a steep patent cliff.
News Euro VCs team up to invigorate life sciences ecosystem Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.
News Novartis breaks ground on San Diego biomedical R&D site Novartis has started construction of a $1.1bn biomedical research centre in San Diego that will serve as the hub for its R&D operations.
Digital Agentic AI: The shift from R&D to R&P will deliver the first... The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
News FDA takes steps to limit non-human primate testing New draft guidance from the FDA says single-target antibodies will no longer need six-month toxicity testing in animals like macaques.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.